These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 11104561
21. ATM variants and cancer risk in breast cancer patients from Southern Finland. Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomäki K, Blomqvist C, Børresen-Dale AL, Nevanlinna H. BMC Cancer; 2006 Aug 16; 6():209. PubMed ID: 16914028 [Abstract] [Full Text] [Related]
22. Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Angèle S, Treilleux I, Tanière P, Martel-Planche G, Vuillaume M, Bailly C, Brémond A, Montesano R, Hall J. Clin Cancer Res; 2000 Sep 16; 6(9):3536-44. PubMed ID: 10999741 [Abstract] [Full Text] [Related]
23. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D. Cancer Epidemiol Biomarkers Prev; 2005 Apr 16; 14(4):821-5. PubMed ID: 15824150 [Abstract] [Full Text] [Related]
24. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility]. Zhang N, Che J, Bai S, Wu Z, Cui Y, Zou W. Sheng Wu Gong Cheng Xue Bao; 2010 Jan 16; 26(1):9-15. PubMed ID: 20353086 [Abstract] [Full Text] [Related]
25. Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Gutiérrez-Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J. Genes Chromosomes Cancer; 2004 Jun 16; 40(2):109-19. PubMed ID: 15101044 [Abstract] [Full Text] [Related]
26. The role of ATM in breast cancer development. Prokopcova J, Kleibl Z, Banwell CM, Pohlreich P. Breast Cancer Res Treat; 2007 Aug 16; 104(2):121-8. PubMed ID: 17061036 [Abstract] [Full Text] [Related]
27. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families. Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J. BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193 [Abstract] [Full Text] [Related]
28. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies. Lu PH, Wei MX, Si SP, Liu X, Shen W, Tao GQ, Chen MB. Breast Cancer Res Treat; 2011 Feb 29; 126(1):141-8. PubMed ID: 20665102 [Abstract] [Full Text] [Related]
29. ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia. Birrell GW, Kneebone K, Nefedov M, Nefedova E, Jartsev MN, Mitsui M, Gatti RA, Lavin MF. Hum Mutat; 2005 Jun 29; 25(6):593. PubMed ID: 15880721 [Abstract] [Full Text] [Related]
30. ATM heterozygosity and cancer risk. Concannon P. Nat Genet; 2002 Sep 29; 32(1):89-90. PubMed ID: 12205473 [No Abstract] [Full Text] [Related]
31. Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients. Austen B, Barone G, Reiman A, Byrd PJ, Baker C, Starczynski J, Nobbs MC, Murphy RP, Enright H, Chaila E, Quinn J, Stankovic T, Pratt G, Taylor AM. Br J Haematol; 2008 Sep 29; 142(6):925-33. PubMed ID: 18573109 [Abstract] [Full Text] [Related]
32. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? Tapia T, Sanchez A, Vallejos M, Alvarez C, Moraga M, Smalley S, Camus M, Alvarez M, Carvallo P. Breast Cancer Res Treat; 2008 Jan 29; 107(2):281-8. PubMed ID: 17351744 [Abstract] [Full Text] [Related]
33. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL. Genes Chromosomes Cancer; 1997 Mar 29; 18(3):175-80. PubMed ID: 9071570 [Abstract] [Full Text] [Related]
34. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. Micol R, Ben Slama L, Suarez F, Le Mignot L, Beauté J, Mahlaoui N, Dubois d'Enghien C, Laugé A, Hall J, Couturier J, Vallée L, Delobel B, Rivier F, Nguyen K, Billette de Villemeur T, Stephan JL, Bordigoni P, Bertrand Y, Aladjidi N, Pedespan JM, Thomas C, Pellier I, Koenig M, Hermine O, Picard C, Moshous D, Neven B, Lanternier F, Blanche S, Tardieu M, Debré M, Fischer A, Stoppa-Lyonnet D, CEREDIH Network Investigators. J Allergy Clin Immunol; 2011 Aug 29; 128(2):382-9.e1. PubMed ID: 21665257 [Abstract] [Full Text] [Related]
35. Two ATM variants and breast cancer risk. Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G, KConFab Investigators. Hum Mutat; 2005 Jun 29; 25(6):594-5. PubMed ID: 15880680 [Abstract] [Full Text] [Related]
36. [What do we know about ATM protein expression in breast tissue?]. Angèle S, Tanière P, Hall J. Bull Cancer; 2001 Jul 29; 88(7):671-5. PubMed ID: 11495820 [Abstract] [Full Text] [Related]
38. Tumor suppressor genes and breast cancer. Buchholz TA, Weil MM, Story MD, Strom EA, Brock WA, McNeese MD. Radiat Oncol Investig; 1999 May 29; 7(2):55-65. PubMed ID: 10333246 [Abstract] [Full Text] [Related]
39. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A. Cancer Res; 1998 Apr 01; 58(7):1376-9. PubMed ID: 9537233 [Abstract] [Full Text] [Related]
40. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling. Waddell N, Jonnalagadda J, Marsh A, Grist S, Jenkins M, Hobson K, Taylor M, Lindeman GJ, Tavtigian SV, Suthers G, Goldgar D, Oefner PJ, kConFab Investigators, Taylor D, Grimmond S, Khanna KK, Chenevix-Trench G. Genes Chromosomes Cancer; 2006 Dec 01; 45(12):1169-81. PubMed ID: 17001622 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]